228 related articles for article (PubMed ID: 25084095)
1. Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.
Lee EY; Kim SS; Lee JS; Kim IJ; Song SH; Cha SK; Park KS; Kang JS; Chung CH
PLoS One; 2014; 9(8):e102984. PubMed ID: 25084095
[TBL] [Abstract][Full Text] [Related]
2. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
3. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
4. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
5. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
6. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
Navarro-González JF; Sánchez-Niño MD; Donate-Correa J; Martín-Núñez E; Ferri C; Pérez-Delgado N; Górriz JL; Martínez-Castelao A; Ortiz A; Mora-Fernández C
Diabetes Care; 2018 Aug; 41(8):1817-1820. PubMed ID: 29866645
[TBL] [Abstract][Full Text] [Related]
7. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.
Karalliedde J; Maltese G; Hill B; Viberti G; Gnudi L
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1899-905. PubMed ID: 23929932
[TBL] [Abstract][Full Text] [Related]
8. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
[TBL] [Abstract][Full Text] [Related]
9. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
10. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
11. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
12. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.
van Ark J; Hammes HP; van Dijk MC; Lexis CP; van der Horst IC; Zeebregts CJ; Vervloet MG; Wolffenbuttel BH; van Goor H; Hillebrands JL
Cardiovasc Diabetol; 2013 Aug; 12():116. PubMed ID: 23945089
[TBL] [Abstract][Full Text] [Related]
13. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
16. Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes.
Liu JJ; Liu S; Morgenthaler NG; Wong MDS; Tavintharan S; Sum CF; Lim SC
Atherosclerosis; 2014 Apr; 233(2):415-418. PubMed ID: 24530772
[TBL] [Abstract][Full Text] [Related]
17. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
[TBL] [Abstract][Full Text] [Related]
19. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria.
Turk N; Mornar A; Mrzljak V; Turk Z
Diabetes Metab; 2004 Apr; 30(2):187-92. PubMed ID: 15223992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
